The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness Yan ZhangMei-Yu HuKang-Da Liu Original Paper 20 June 2006 Pages: 685 - 697
Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma G. TreiberT. WexP. Malfertheiner Original Paper 12 July 2006 Pages: 699 - 708
The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma Hui ZhangQing-Hai YeLun-Xiu Qin Original Paper 20 June 2006 Pages: 709 - 717
Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib Shigenori KanazawaKazuyuki YamaguchiShosaku Nomura Original Paper 12 July 2006 Pages: 719 - 725
Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer Andrei AnghelMarius RaicaOana Mitrasca Original Paper 22 June 2006 Pages: 727 - 733
Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa Keizo KatoAkira HaraToshiyuki Shibata Original Paper 22 June 2006 Pages: 735 - 743
Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy Thomas J. VoglWolfram SchwarzMatthias Heller Original Paper 21 July 2006 Pages: 745 - 755